香雪XPH品牌怎么样 申请店铺

我要投票 香雪XPH在医疗器械行业中的票数:147 更新时间:2025-04-02
香雪XPH是哪个国家的品牌?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!通过在本页面挂载香雪XPH品牌的产品链接和联系邮箱,可以提高香雪XPH产品曝光!跨境电商爆单神器,目前只要100元/年哦~

香雪XPH怎么样

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://brand.waitui.com/5a03ebbad.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

伊利股份:已回购3250.54万股,使用资金总额7.68亿元

36氪获悉,伊利股份公告,公司于2024年4月28日董事会审议通过回购股份方案,计划以10亿元至20亿元资金,通过集中竞价方式回购股份以注销减少注册资本。截至2025年3月,公司累计回购3250.54万股,占公司总股本的0.5106%,回购价格区间为21.57元/股至27.79元/股,累计使用资金7.68亿元人民币。

51分钟前

利民股份:代森锰锌产品目前满负荷生产,对新询单暂停报价

36氪获悉,利民股份今日在互动平台表示,代森锰锌产品由于海外市场需求,目前公司满负荷生产,对新询单暂停报价,后续公司将根据市场变化及时做出价格政策调整。

51分钟前

兰州助剂启动北交所IPO辅导

36氪获悉,兰州助剂厂股份有限公司上市辅导备案材料近日获备案登记,辅导机构为申万宏源。该公司从事引发剂生产,拟在北交所IPO。

51分钟前

欧盟委员会提议放宽车企碳排放规则

欧盟委员会4月1日提出一项法规修订方案,提议在新的乘用车和厢式货车二氧化碳减排目标方面,给予欧洲汽车制造商更灵活的排放合规选项,将允许汽车制造商在2025年至2027年内,不按年度审核而是以这3年的平均二氧化碳排放水平来衡量是否达到减排目标。该方案还需得到欧洲议会和欧盟理事会批准。(新华社)

51分钟前

竹芒科技发布彩宝3.0 Pro

4月1日,拥有街电搜电两大品牌的竹芒科技发布了彩宝3.0系列新品和智能运营平台。据介绍,彩宝3.0Pro柜机在硬件防护方面,采用了军工级防护体系。具备IPX4防水设计,行业首创的“控水机架”实现前后干湿分离,即使在潮湿的环境中也能正常运行。此次发布的充电宝3.0 Pro产品拥有10000mAh容量,配合22.5W超级快充,实测30分钟可充至80%,以此大幅提升用户使用体验。智能运营方面,AI调度功能将提升资产流转效率35%,全面优化代理商运维能力。

51分钟前

本页详细列出关于仁和可立克的品牌信息,含品牌所属公司介绍,仁和可立克所处行业的品牌地位及优势。
咨询